Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-011078

Chief Operating Officer gave up 1,571 shares (to pay taxes)

  • Chief Operating Officer acquired 3,514 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-31 Exercise or conversion : show line 1 in the form +3,514 54,240 D
2026-03-31 Shares withheld for taxes : show line 2 in the form −1,571 $54.79 $86,075 52,669 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-31 Exercise or conversion : show line 3 in the form Restricted Stock Unit −3,514 44,753 D
Loading xslF345X06/rdgdoc.xml…